BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31573757)

  • 1. Prognostic role of pre-treatment serum albumin in patients with nasopharyngeal carcinoma: A meta-analysis and systematic review.
    Yang H; Wang K; Liang Z; Guo S; Zhang P; Xu Y; Zhou H
    Clin Otolaryngol; 2020 Mar; 45(2):167-176. PubMed ID: 31573757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
    Gao N; Yang RN; Meng Z; Wang WH
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
    Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
    Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
    Tu X; Ren J; Zhao Y
    Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Serum Lactate Dehydrogenase in Patients with Nasopharyngeal Carcinoma: a Meta-Analysis.
    Zhai C; Gu K; Zhai X; Wang J; Zhang J
    Clin Lab; 2017 Nov; 63(11):1777-1785. PubMed ID: 29226643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
    Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
    Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
    Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
    Zhang Y; Yang X
    Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Su L; Zhang M; Zhang W; Cai C; Hong J
    Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma.
    Mo HY; Luo DH; Qiu HZ; Liu H; Chen QY; Tang LQ; Zhong ZL; Huang PY; Zhao ZJ; Zhang CQ; Zhang Y; Mai HQ
    Clin Oncol (R Coll Radiol); 2013 May; 25(5):308-17. PubMed ID: 23290342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of Epstein-Barr virus DNA level for nasopharyngeal carcinoma: a meta-analysis of 8128 cases.
    Qu H; Huang Y; Zhao S; Zhou Y; Lv W
    Eur Arch Otorhinolaryngol; 2020 Jan; 277(1):9-18. PubMed ID: 31659449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of neutrophil-lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis.
    Takenaka Y; Kitamura T; Oya R; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
    PLoS One; 2017; 12(7):e0181478. PubMed ID: 28715474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
    Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
    Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment age and serum lactate dehydrogenase as predictors of synchronous second primary cancer in patients with nasopharyngeal carcinoma.
    Yeh CF; Ho CY; Chin YC; Shu CH; Chao YT; Lan MY
    Oral Oncol; 2020 Nov; 110():104990. PubMed ID: 32932171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma: A meta-analysis.
    Yin J; Qin Y; Luo YK; Feng M; Lang JY
    Medicine (Baltimore); 2017 Jul; 96(29):e7577. PubMed ID: 28723793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment low prognostic nutritional index and low albumin-globulin ratio are predictive for overall survival in nasopharyngeal cancer.
    Gundog M; Basaran H
    Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3221-3230. PubMed ID: 31401760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma.
    Lu X; Qian CN; Mu YG; Li NW; Li S; Zhang HB; Li SW; Wang FL; Guo X; Xiang YQ
    Eur J Cancer; 2011 Feb; 47(3):339-46. PubMed ID: 20951575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
    Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
    Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined chemoradiation vs radiation therapy alone in stage-II nasopharyngeal carcinoma: A meta-analysis of the published literature.
    Wang S; Li S; Shen L
    Curr Probl Cancer; 2018; 42(3):302-318. PubMed ID: 29759802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.